Based on data collected from different sources by our team,
there are indicators that suggest that this company is no longer active. However, this information may not be accurate.
If you believe this information should be updated, please .
For more details, you can read our .
TargetGene Biotechnologies
TargetGene Biotechnologies Overview
TargetGene Biotechnologies is an innovative and agile biotechnology company in its development stage and poised for expansion. The companys R&D is centered around creating efficient and extremely specific DNA editing solutions in living organisms.
Through its patented and patent-pending TGEE (genome editing engine) platform, TargetGene has developed RNA-guided gene targeting. The company aims to implement the TGEE platform for human gene therapy with a focus on inherited diseases and cell-based immunotherapy.
Interview: Move over CRISPR: a new platform, TGEE, could soon replace everybody's favorite gene editing tool. Interview: Yoel Shiboleth, CEO TargetGene - CRISPR Medicine
#Investment #Expand
Dec 26, 2018
en.globes.co.il
TargetGene develops more precise gene editing
#Investment #Partners
May 7, 2017
www.wsj.com
Next Phase of High-Tech Crops: Editing Their Genes
Interview: Move over CRISPR: a new platform, TGEE, could soon replace everybody's favorite gene editing tool. Interview: Yoel Shiboleth, CEO TargetGene - CRISPR Medicine
#Investment #Expand
Dec 26, 2018
en.globes.co.il
TargetGene develops more precise gene editing
#Investment #Partners
May 7, 2017
www.wsj.com
Next Phase of High-Tech Crops: Editing Their Genes